Enzyceuticals

EnzyCeuticals is a biotechnology company founded in 2021 as a spin-off from the Agricultural University of Athens. The company specializes in the development and manufacture of innovative, high-quality enzymes and enzyme-based products for the food, health, and cosmetic industries. They utilize their proprietary iEζC platform technology, which integrates omics, bioinformatics, artificial intelligence, synthetic biotechnology, and protein engineering to accelerate enzyme discovery and design. Their offerings include a diverse portfolio of recombinant and native enzymes, proprietary Xenobody protein libraries, and affinity adsorbents, with production maintained under ISO 9001 standards.

These solutions enable customers across various sectors to implement sustainable enzymatic processes. By leveraging their cross-disciplinary expertise, EnzyCeuticals provides novel candidates for applications such as biosensing, bioscavenging, biocatalysis, and drug delivery. The company is recognized as an official member of the Greek startup ecosystem, Elevate Greece, and focuses on developing safe, sustainable, and financially viable enzyme technologies to drive the enzyme bioeconomy. Their work supports both R&D initiatives and industrial-scale requirements, helping partners optimize their operations through advanced biotechnological routes.